Product detail

SEMA

Semaglutide is a 31-amino-acid glucagon-like peptide-1 (GLP-1) receptor agonist with 94% homology to native GLP-1. Modified with a C18 fatty di-acid chain attached via a spacer to the lysine at position 26, this modification enables extended half-life through albumin binding. Research has extensively studied its effects on glycemic control, appetite regulation, and body weight management.